Related by context. All words. (Click for frequent words.) 65 VACATE 63 REMAND 62 AFFIRMED 57 hereby AFFIRMED 57 summarily affirm 57 REMANDED 54 summary judgment de novo 53 MIST II 52 ORDERED ADJUDGED AND DECREED 52 IT IS HEREBY 51 Case No. A#A# 50 ADJUDGED 50 evidentiary rulings 50 sua sponte dismissal 50 overrule appellant 50 Eleventh Circuit affirmed 50 IT IS THEREFORE 49 hereby DISMISSED 49 substantive reasonableness 49 DISMISS 49 JNOV 49 Val HeFT 48 affirmance 48 UCBR 48 jurisdictional prerequisite 48 IN PART 48 CAFC affirmed 48 DECREED 48 substantively reasonable 48 UPON DUE CONSIDERATION 47 lorvotuzumab mertansine 47 argument unpersuasive 47 Ibid. 47 DENY 47 Appellants argue 47 hereby GRANTED 47 COSIRA trial 47 WITH PREJUDICE 47 Phase IIB 47 PrevOnco 47 Opening Br 46 GRANTED 46 factual sufficiency 46 judicial estoppel 46 postjudgment 46 liberally construe 46 Appellate Division affirmed 46 procedural reasonableness 46 coram nobis 46 granted certiorari 46 reviewed de novo 46 ore tenus 46 nonsuit 46 Defendants Respondents 46 JMOL 46 habeas relief 45 La.Civ.Code art 45 granting summary judgment 45 collaterally attack 45 u pon 45 AND ADJUDGED 45 reasonable inferences drawn 45 Reply Brief 45 Ex Post Facto 45 Claimant argues 45 Ninth Circuit affirmed 45 appellant contends 45 c ounsel 45 vacatur 45 DISMISSED WITH PREJUDICE 45 de novo 45 phase IIb clinical 45 IT IS ORDERED 45 credibility determinations 45 dose escalation clinical 45 Appellants contend 45 MR Civ 44 Appellate Term 44 mandamus petition 44 appellant asserts 44 State ex rel 44 factual determinations 44 issue preclusion 44 IMPACT DCM clinical 44 post hoc 44 Ophena 44 Lenocta 44 ULJ 44 PIX# trial 44 State Farm Mut 44 Exercising jurisdiction 44 respectfully dissent 44 legitimate nondiscriminatory 44 NCGS § 7B 44 remittitur 44 Phase Ib study 44 Order Granting 44 Plaintiffs Appellants 44 factual predicate 44 hereby DENIED 44 GLASS ART Trial 44 affirm 44 Petitioner contends 44 Files Amicus Brief 44 § #E#.# 44 USSG § #G#.# 44 Petitioner argues 44 seeks declaratory 44 Collateral estoppel 44 confirmatory Phase 44 certiorari 43 error coram nobis 43 interlocutory orders 43 § #A.# 43 posttrial motion 43 Solicitor Chrissy Adams 43 Zevalin consolidation 43 Eleventh Circuit 43 improvidently granted 43 contemporaneous objection 43 BIA denial 43 App'x 43 phase Ib clinical 43 trastuzumab DM1 T DM1 43 sua sponte 43 additur 43 Respondent concedes 43 IRCP 43 procedurally unreasonable 43 rehearing en banc 43 epigenetic therapies 43 Second Amended Complaint 43 ZHB 43 adjudicating guilt 43 heavily pretreated 43 Abe Motala 43 Younger abstention 43 dose escalation phase 43 certiorari prohibition 43 Hofsheier 43 Presentence Investigation Report 43 Preliminary Injunction Against 43 blinded randomized placebo controlled 43 Appeals Affirms 43 § #A [002] 43 noninfringement 43 hereby ORDERED 43 Petitioner asserts 42 habeas proceeding 42 nonfinal 42 determinations de novo 42 BLA filing 42 appealability 42 USSG § 42 GL c 42 Defendant argues 42 postconviction relief 42 Sentencing Guidelines Manual 42 evidence preponderates 42 Dismiss Plaintiff 42 CLASS ACTION 42 NEUVENGE 42 b Vernon Supp 42 substantively unconscionable 42 Summary Judgment Order 42 ResQNet 42 PLEASE TAKE NOTICE 42 uncontroverted facts 42 Colo. Sess 42 Appellate Division reversed 42 Ark. R. Civ 42 asymptomatic metastatic 42 Appellants 42 No. B# 42 OvaRex MAb 42 PCRA petition 42 conclusions de novo 42 plainly erred 42 Cloretazine 42 confirmatory clinical 42 retrospective observational study 42 vernakalant hydrochloride 42 Judges Sonya Sotomayor 42 Petitioners contend 42 VETO HB 42 Markman Order 42 4th DCA 42 Apprendi 42 equitable tolling 42 Intervenors 42 Defendant asserts 42 appellants contend 42 posttrial motions 42 MGd 42 clinicopathological features 42 CrR #.# 42 Cloretazine VNP#M 42 Tenn. R. Civ 42 drawn therefrom 42 granted summary judgment 42 arguable merit 41 People v. Gardeley 41 § #K#.# 41 Defendant contends 41 Xanafide 41 res judicata 41 Plaintiff asserts 41 mootness 41 § #-#-# [006] 41 En Banc 41 Elias Zacarias 41 induced macular edema 41 mistake inadvertence surprise 41 collateral estoppel 41 factually distinguishable 41 § #B#.# [002] 41 counterclaims asserted 41 mandamus proceeding 41 JNOV motion 41 De Varon 41 Phase #b/#a trial 41 Appellant asserts 41 Fla. 2d DCA 41 lodestar method 41 Partial Summary Judgment 41 Tax Injunction 41 respectfully submits 41 pharmacodynamic PD 41 Hedgehog Pathway Inhibitor 41 Injunctive Relief 41 Shareholder Derivative 41 Pa.RAP 41 habeas petitioner 41 PLAVIX R patent 41 assume arguendo 41 defendants appellees 41 equitable estoppel 41 USSG § #E#.# 41 SinuNase 41 en banc rehearing 41 NDCC ch 41 initiate Phase 1b 41 procedurally barred 41 hyperoxaluria 41 claim preclusion 41 compel arbitration 41 Reply Br 41 Tenth Circuit 41 Code Civ 41 ex rel 41 People v. Waidla 41 Construing 41 #K#.# 41 Fla. 3d DCA 41 dose escalation Phase 41 prejudice prong 40 Relators 40 postconviction petition 40 PXD# 40 People v. Carmony 40 reweigh 40 Requester 40 Repl. 40 Tanys Lancaster Jill Patricot 40 court Wash. ecoterror 40 Rule #:#-# [002] 40 substantively unreasonable 40 brivaracetam 40 Defendants assert 40 BPAI 40 Rooker Feldman 40 § #-#.# [002] 40 Scheidler v. 40 Seventh Circuit 40 Study #CL# 40 Section #-#-# [006] 40 CPLR article 40 mem. op 40 inhaled anticholinergics 40 nonappealable 40 anti SLAPP motion 40 peremptory writ 40 Dkt. # 40 summary affirmance 40 Markman Hearing 40 excusable neglect 40 CLIA Clinical 40 Phase III metastatic melanoma 40 tubulin inhibitor 40 recurrent glioma 40 replead 40 AEDPA 40 Minn. R. Crim 40 Judicial Proceedings Article 40 w hether 40 RSD# oral 40 bioequivalency 40 ResponseDX Lung TM 40 RCr #.# 40 placebo controlled multicenter 40 Appellant contends 40 biliary tract cancer 40 adjuvant systemic 40 reexamination proceeding 40 tesmilifene 40 Third Amended Complaint 40 constitutionally deficient 40 ERISA § 40 CEQA Guidelines 40 p rior 40 PDE# inhibitors 40 Spreigl evidence 40 modified categorical 40 Interlocutory 40 summary adjudication 40 Tex. Code 40 Eleventh Judicial 40 § #C#.# 40 AnimalFeeds 40 Therasense 40 Declaratory Judgment 40 Datuk Ramly Ali 40 5th DCA 40 Amended Judgment 40 Luminex expressly disclaims 40 OCGA § #-#-# [007] 40 OCGA § #-#-# [004] 40 laches 40 WCJ 40 P. #a 40 TAXUS V 40 Permanent Injunction 40 T#I [002] 40 postconviction 39 fallopian tube cancers 39 reh'g 39 MyVax ® 39 Xcellerated T Cells 39 Carabell v. 39 Settling Defendants 39 appellants 39 promissory fraud 39 enzastaurin 39 establish prima facie 39 LSA RS #:# [002] 39 completely resected 39 § #L#.# 39 affirmative defenses 39 Civil Procedure Rule 39 USC § #A 39 plea colloquy 39 thoracoscopic lobectomy 39 summary judgment motions 39 Defendant Scrushy 39 European Sepsis Trial 39 SLAR 39 papillary renal cell carcinoma 39 Ninth Circuit 39 Al Odah v. 39 YOU ARE HEREBY NOTIFIED 39 § #.# subd [005] 39 Allvoice 39 manifestly unreasonable 39 procedurally defaulted 39 delipidation 39 cardio renal 39 dispositive motion 39 adjudicative functions 39 TRISENOX 39 Rooker Feldman doctrine 39 doxorubicin Transdrug ® 39 overturns Arthur Andersen 39 Nucleic Acid Detection Immunoassay 39 Slip Op 39 statutorily authorized 39 § #.# [002] 39 BHT DNA 39 CFR § #.# [006] 39 Joint Stipulation 39 VerifyNow P#Y# 39 Sentencing Guidelines Manual USSG 39 VETO SB 39 Judgments § 39 Cal.App 39 remanding 39 Lord Mance 39 La.Code Crim.P. art 39 RC #.# B [001] 39 unfavorable cytogenetics 39 Biologics License Applications 39 nonfrivolous 39 CINA 39 CFR § #.# [003] 39 Preliminary Injunction 39 plainly erroneous 39 extracranial 39 reversible error 39 nonjurisdictional 39 PAOD 39 partial summary judgment 39 Evid 39 Claimant contends 39 Fam. Code § 39 Adversary Proceeding 39 Zavesca r 39 revascularization procedure 39 Summary Judgment 39 § #-#-# [002] 39 SDNY Mar. 39 supersedeas 39 Plaintiff Complaint 39 DermTech International 39 factfinder 39 Dacogen injection 39 postconviction counsel 39 xxxi adverse tax 39 § #-# [004] 39 appellees 39 generalizability 39 nondischargeability 39 Certiorari 39 People v. Doganiere 38 patent invalidity 38 legitimate nondiscriminatory reasons 38 Accelerated Approval 38 hewing faithfully 38 presumptively valid 38 hearsay objection 38 postconviction motion 38 PSVT 38 ABSSSI 38 Circuit LAR 38 Michele Granda 38 Xiu Xia Lin 38 WHEREFORE 38 BioSTAR ® 38 posttrial 38 CrR 38 haematologic 38 FEHA 38 Plaintiff contends 38 #.# subd [004] 38 interlocutory appeal 38 Slip op 38 § #A#.# 38 § #-#-# [004] 38 Safeco Ins 38 RCW #.#A.# 38 Premarket Approval 38 al Odah v. 38 Summary Judgement 38 mentioned AB Culvahouse 38 Title VII retaliation 38 Rule #:#-# [001] 38 univariate 38 granting appellee 38 myeloproliferative 38 § #.#.# [001] 38 dose escalation 38 equitable subrogation 38 Plaintiffs Counsel 38 CFR § #.# [005] 38 presentence credits 38 #cv# [002] 38 Habeas Corpus Petition 38 Rehearing 38 Minn. Stat 38 Daubert v. 38 USC § 38 CFR § #.# [002] 38 colorable claim 38 overbreadth 38 IC § #-# 38 NJRE 38 res ipsa 38 O'Scannlain wrote 38 ex parte reexamination 38 DEEP AF 38 Judgment affirmed 38 WISCONSIN STAT 38 Second Amended 38 #B#.# 38 Telatinib 38 NJSA 2A #A 38 Sixth Circuit 38 nunc pro tunc 38 BLA submission 38 limine 38 aff'd 38 classwide 38 c ourt 38 ADAAA 38 CFR § #.# [008] 38 Eighth Amendment prohibits 38 bifurcated proceeding 38 construed liberally 38 Powerlink XL 38 f ailure 38 appealability COA 38 nonobviousness 38 mutational analysis 38 dispositional 38 Amended Complaint 38 untimeliness 38 factual underpinnings 38 fi ndings 38 myeloproliferative diseases 38 deposition excerpted 38 reasonable factfinder 38 inter partes 38 supplemental Biologics License Application 38 IJ denial 38 intentional relinquishment 38 Summary Judgment Doc. 38 histologies 38 medicine EBM 38 injunctive reliefs 38 § #B#.# [001] 38 retrospectively reviewed 38 Doganiere 38 proximate causation 38 evidentiary objections 38 preliminary injunctive relief 38 § #e 38 Code § #-#.# 38 controverted 38 thorough QT 38 psychiatric comorbidity 38 reh'g denied 38 facially invalid 38 estopped 38 nonfrivolous issue 38 USSG § #B#.# [002] 38 Wyo. Stat 38 p# biomarker 38 Riegel v. 37 sua sponte duty 37 habeas 37 Verified Complaint 37 unpatentability 37 Chaudhry Ijaz Ahmed 37 USSG § #A#.# b 37 MPEP 37 FURTHER ORDERED 37 CALJIC No. #.# 37 ¶ 37 habeas statute 37 Hamdi v. 37 #-# SDNY 37 Counterclaim 37 liberally construing 37 dispositive motions 37 Amended Petition 37 parol evidence 37 CFR § #.# [004] 37 Movants 37 plead scienter 37 n otwithstanding 37 movant 37 lenity 37 § #b [002] 37 #.# subd [006] 37 underwent surgical resection 37 dispositive procedural ruling 37 ATL# [001] 37 gefitinib Iressa 37 establishes prima facie 37 summary judgment 37 Appellant argues 37 NJSA #:#-# [004] 37 non infringement invalidity 37 CLIA waiver 37 facially neutral 37 Judge Luckern 37 § #G#.# 37 USSG § #D#.# 37 Stephen Breyer dissented 37 Faretta motion 37 dispositional order 37 procedurally err 37 palifosfamide 37 #.# subds [001] 37 § #.# [003] 37 pharmacogenetic testing 37 stage IIIA 37 First Amended Complaint 37 Aplt 37 #.# subdivision [002] 37 purposeful availment 37 La. RS #:# [002] 37 unconscionability 37 § #a [002] 37 restenotic lesions 37 SVPA 37 demurrer 37 § #-#-# b [001] 37 kidney urologic 37 ARS § 37 equitable indemnity 37 COLD PCR 37 order sustaining demurrer 37 desisyon ng 37 Supp. 37 Geier supra 37 preclusive effect 37 Presentence Report 37 Defendants 37 pro se 37 habeas proceedings 37 No. BC# 37 squamous cell histology 37 ENMD # 37 compensability 37 OCGA § #-#-# [008] 37 Wis. Stat 37 CRCP 37 requestor petitioner 37 nontestimonial 37 relators 37 subsection h 37 Appellants assert 37 ALJ Initial Determination 37 remission induction 37 RC #.# B [002] 37 restitutionary 37 Bankruptcy Procedure 37 assuming arguendo 37 Please respond insightfully 37 Merit Sys 37 section #.#.# 37 reargument 37 uncontroverted testimony 37 essential thrombocythemia 37 Neo Bladder Augment 37 KRAS mutation 37 FLT3 mutations 37 methotrexate monotherapy 37 ResponseDX Colon TM 37 adjuvant therapies 37 Declaratory Judgment Act 37 reexaminations 37 Torts § 37 molecular profiling 37 interlocutory 37 inequitable conduct 37 v Zvi Goffer 37 compound PMX # 37 #.# subds [003] 37 Janet Loures 37 Justice Abdullahi Mustapha 37 USSG § #L#.# 36 pleadings liberally 36 prosecutorial vindictiveness 36 ALJs 36 People v. Breverman 36 § #.# b 36 Prudential Ins 36 qui tam provisions 36 declarants 36 subds 36 echocardiographic 36 Batson v. 36 court procedurally erred 36 § #-#-# [003] 36 colorectal liver metastases 36 CFR #.# [008] 36 Tennard 36 G#DT 36 pari materia 36 Individual Defendants 36 s ince 36 presumptively prejudicial 36 KSA #-# d 36 pro hac vice 36 talabostat 36 Stipulated 36 jurisdictional defect 36 habeas petition 36 Secured Creditor 36 section #.# subdivision 36 Grupo Mexicano 36 reasonably infer 36 § #.# [004] 36 Rehear 36 injunction precluding 36 caustically droll Sheen 36 Plaintiffs contend 36 Temporary Injunction 36 propria persona 36 motu propio 36 postconviction proceedings 36 subparagraph B 36 declaratory judgments 36 Pen. Code § #.# [001] 36 titrated glipizide 36 pretermitted 36 equitable mootness 36 Defendant Appellee 36 misapprehends 36 gravamen 36 Rickey Tarfa 36 hematopoietic cancers 36 WOULD YOU RATHER 36 PS § 36 TCA § #-#-# [003] 36 HRS § #-# [002] 36 estoppel 36 Respondent contends 36 OCGA § #-#-# [005] 36 Consent Judgment 36 La. Code Civ 36 Interferon alfa 36 Due Process Clause 36 instruct sua sponte 36 Rosenkrantz supra 36 LEUKINE 36 antenuptial agreement 36 KRAS wild 36 P laintiff 36 pancreatic adenocarcinoma 36 Ala. R. Crim 36 RainStorm 36 SNP Genotyping 36 Civil Procedure section 36 arbitrability 36 miRview ™ meso 36 impugned judgment 36 Boumediene v. Bush 36 factual contentions 36 Evid. Code § § 36 Evid. Code § 36 La.Code Civ.P. art 36 reasonably deduce 36 Writs Act 36 Faretta 36 expressly disavowed 36 Assuming arguendo 36 construing statute 36 SOAH 36 inter partes reexamination 36 IMiD 36 b ased 36 Appellees 36 MHPAEA 36 offer competi MORE 36 n.2 36 draw reasonable inferences 36 Fed.R.Civ.P. 36 Roman Rota 36 DC Code § 36 voluntariness 36 nonfrivolous issues 36 collaterally estopped 36 postjudgment motion 36 Judge Algenon L. 36 anti SLAPP statute 36 SOF ¶ 36 Rule Nisi 36 CFR § #.# [007] 36 noncapital 36 Code § #.#-# [001] 36 § #-# [001] 36 antisense oligonucleotides 36 procedurally defective 36 aged ≥ 36 SLNB 36 statutorily ineligible 36 angiotensin converting enzyme inhibitors 36 reweighing 35 Reinholtsen 35 telavancin NDA 35 medically inoperable 35 hip resurfacing arthroplasty 35 Civ. Code § 35 NDNY 35 § #-#-# c [001] 35 Boykin Tahl 35 summary judgment motion 35 oncologic 35 Norwich Pharmacal 35 § #-#-# [008] 35 obviousness rejection 35 respectfully disagree 35 strictly construe 35 internal citation omitted 35 ORDERED 35 subsection d 35 Manila RTC 35 JANE DOE 35 § 7B 35 n.9 35 attorney Clement Donelon 35 RCW #.#.# [003] 35 summary judgment dismissing 35 ResponseDX Lung ™ 35 raise triable 35 interlocutory injunctions 35 n othing 35 section #.# 35 miRview ® 35 Double Jeopardy Clause 35 Counterclaims 35 HCV genotype 1 35 App.R. 35 impermissible intrusion 35 parental unfitness 35 purposefully availed itself 35 p laintiff 35 judgment nunc pro 35 prima facie case 35 appealable 35 judicially reviewable 35 inapposite 35 predicate 35 deportability 35 chemoresistant 35 #a subdivision 35 Anti Injunction 35 affd 35 n.7 35 interlocutory injunction restraining 35 forum non conveniens 35 Rule #:#-# e 35 Interim Injunction 35 THECB 35 nonstatutory 35 Judge Scheindlin 35 Cal. App 35 quasi judicial immunity 35 8th Judicial Circuit 35 RCr 35 NFTL 35 #.# subd [002] 35 Section #.#.# [001] 35 justiciability 35 prima facia 35 construing 35 BrachySil TM 35 Superior Court Appellate Division 35 ganaxolone 35 immunodeficiencies 35 Nabi HB Intravenous 35 statutorily prescribed 35 Equitable tolling 35 equitably estopped 35 n.5 35 No. #AP 35 u nder 35 Plaintiff Appellant 35 NYCHRL 35 en banc 35 Id. 35 rhIGFBP 3 35 Subjecting prisoner abuse 35 § #D#.# 35 myeloproliferative disorders 35 controvert 35 Justice Saka Ibiyeye 35 #cv# [001] 35 NASD Marketplace Rule 35 reasonableness 35 § #-#-# [001] 35 Assistant Appellate Defender 35 Symadex 35 § #.#-# [001] 35 Montoya jockeyed 35 Crim.R. 35 interrogatory answers 35 WCAB 35 USSG § #K#.# b 35 substantive unreasonableness 35 Voir dire 35 psychometrically sound 35 CALCRIM Nos. 35 USC § #e 35 § #-#-#.# 35 Seventh Circuits 35 appealable interlocutory 35 compulsory counterclaim 35 ORS #B.# 35 indigency 35 methotrexate therapy 35 promissory estoppel 35 ALJ erred 35 preponderate 35 subsections b 35 Selangor Syariah 35 requisite scienter 35 ascertainment 35 relator 35 hereby waives 35 Cutanea 35 USSG § #D#.# b 35 HRS § #-# [001] 35 inter parte 35 v. Cavera 35 e ach 35 NJSA 2C :5 35 immunohistochemical 35 contractual indemnification 35 promissory estoppel claim 35 radiochemotherapy 35 TMPRSS2 ERG fusion 35 res gestae 35 erythema nodosum 35 RapidChek SELECT 35 ASBCA 35 mootness doctrine 35 internal citations omitted 35 Dahiru Musdapher 35 ALJ 35 NJSA #:#-#.# [001] 35 Joinder 35 § #A [001] 35 § #.# [001] 35 Isolagen Process 35 rHuPH# 35 writ ref'd nre 35 carcinoma HCC 35 permanently enjoin 34 Intervenor 34 Celotex Corp. 34 Penal Code section 34 peripheral blood mononuclear 34 Act RFRA 34 conclusory 34 adequately pled 34 § #A [003] 34 Court. Judgment 34 declaratory relief 34 court prejudicially erred 34 Petitioner 34 diocesan canons 34 curative instruction 34 ICAs 34 Gratz v. Bollinger 34 VIOXX Litigation 34 Surgical resection 34 IJ adverse 34 u nless 34 Rule #:#-# b 34 factfinding 34 generalizable 34 JAK inhibitors 34 USCA § 34 Diabetic macular edema 34 Trustee Objection 34 RC #.# [002] 34 e vidence 34 La. RS #:# [003] 34 pendency 34 KRS #.# [003] 34 Ex parte Young 34 contemporaneous objection rule 34 #.# subdivision [004] 34 methodological differences 34 quantum meruit 34 Defendants misrepresented 34 subtitue prizing 34 son Arlam 34 particularized facts 34 PathFinderTG 34 inapplicability 34 Baseline characteristics 34 Judge Kermit Lipez 34 AtherOx 34 Subsection b 34 violated SCR #:#.# 34 Interrogatory No. 34 Restatement Second 34 NJSA #:#-#.# [003] 34 declaratory judgment 34 People v. Falsetta 34 res ipsa loquitur 34 spds cgma turbos # s# 1 34 preclude summary judgment 34 bsent 34 d efendant 34 ll.# 34 adduce evidence 34 Werdegar wrote 34 KSA #-# [001] 34 PCA Directive 34 § #K#.# b 34 miRview TM meso 34 § #L#.# b 34 Colorado Revised Statutes 34 Eighth Amendments 34 unduly prejudiced 34 FEGR disclaims 34 antiangiogenic agent 34 Elafin 34 injunctive relief 34 appellant 34 OrCel ® 34 similarly situated 34 appealable judgment 34 Moench presumption 34 ORS #A.#